Left ventricular response after cardiac resynchronization therapy is related to early left atrial volume reduction by 강석민 et al.
Copyright © 2020 The Korean Association of Internal Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/





Korean J Intern Med 2020;35:1125-1135
https://doi.org/10.3904/kjim.2018.430
1Division of Cardiology, Department 
of Internal Medicine, Ewha Womans 
University Seoul Hospital, Seoul; 
2Division of Cardiology, Department 
of Internal Medicine, Severance 
Cardiovascular Hospital, Yonsei 
University College of Medicine, Seoul, 
Korea
Received : November 29, 2018
Revised : March 30, 2019
Accepted : April 3, 2019
Correspondence to
Seok-Min Kang, M.D.
Division of Cardiology, Severance 
Cardiovascular Hospital, Yonsei 
University College of Medicine, 





Background/Aims: The current study aimed to elucidate a time-course change 
in left atrial volume after cardiac resynchronization therapy (CRT) and to verify 
factors associated with left atrial volume reduction (LAVR) and its prognostic im-
plications.
Methods: The records of 97 patients were retrospectively reviewed after CRT. 
Echocardiographic data were analyzed at baseline before CRT, at early follow-up 
(FU) (≤ 1 year, median 6 months), and at late FU (median 30 months). Left ventric-
ular volume response (LVVR) was defined as 15% reduction in left ventricular (LV) 
end-systolic volume (ESV). LAVR was classified into two groups by the median 
value at early FU: LAVR (≥ 7.5%) and no LAVR (< 7.5%).
Results: LV ESV index continuously decreased from baseline to early FU and from 
early FU to late FU (106.1 ± 47.4 mL/m2 vs. 87.6 ± 51.6 mL/m2 vs. 72.5 ± 57.1 mL/m2). 
LA volume index decreased from baseline to early FU, but there were no reduc-
tions thereafter (51.8 ± 21.9 mL/m2 vs. 45.1 ± 19.6 mL/m2 vs. 44.9 ± 23.0 mL/m2). 
The only echocardiographic factor associated with LAVR was change in E velocity 
(odds ratio [OR], 1.04; p = 0.002). Early LAVR (OR, 10.05; p = 0.002) was an indepen-
dent predictor for late LVVR. 
Conclusions: LAVR was related to reduction in E velocity, suggesting its relation 
with optimization of LV filling pressure. Early LAVR was a predictor for LVVR to 
CRT in long-term FU.
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INTRODUCTION
Cardiac resynchronization therapy (CRT) improves symp-
toms and survival in patients with medically refractory 
heart failure and left ventricular (LV) systolic dysfunction 
with electrical dyssynchrony [1]. The beneficial clinical 
outcomes have mainly been attributed to significant re-
duction in LV end-systolic volume (ESV) [2]. Several stud-
ies have indicated that reduced left atrial (LA) size after 
CRT device implantation was also associated with favor-
able clinical outcomes [3,4], suggesting that reductions 
in both LA and LV volumes predict clinical outcomes 
in patients with an implanted CRT device. However, in-
dividual variability of reductions in LA and LV volumes 
after CRT has been described and a considerable pro-
portion of patients showed discordant reductions in LA 
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and LV volumes in a previous study [5].
CRT restores the homogeneous LV contraction pat-
tern, thus reducing LV ESV and improving systolic 
function. CRT induces LV volume reduction (LVVR) 
that can be sustained for up to 3 years [6]. However, the 
time-course of changes in LA volume has not been well 
investigated after CRT. LA volume is a morphologic 
expression of the severity and chronicity of LV diastol-
ic dysfunction and LV filling pressure because the left 
atrium is directly exposed to pressures in the LV that 
increase with decreased LV compliance during diasto-
le [7]. Therefore, hemodynamic factors during diastole 
may determine LA volume reduction (LAVR) after CRT 
and the time-course of LAVR may be different from that 
of LVVR.
The objectives of this study were (1) to assess changes 
in LAVR after CRT device implantation, (2) to investigate 
the time-course relationship between LAVR and LVVR, 
and (3) to identify echocardiographic factors associated 
with LAVR and their clinical implications. 
METHODS
Study population
Medical records of 97 consecutive patients who under-
went CRT-pacemaker or CRT-defibrillator implanta-
tion between February 2010 and October 2016 at an adult 
heart failure clinic of a tertiary referral hospital (Sever-
ance Cardiovascular Hospital, Seoul, Korea) were retro-
spectively reviewed. Echocardiographic data at baseline 
before CRT device implantation, at early follow-up (FU) 
(≤ 1 year after device implantation), and at late FU (last 
echocardiography acquired during FU period) were ana-
lyzed. Patients were classified into two groups as follows 
according to the median value of LAVR at early FU: (1) 
LAVR and (2) No LAVR. LV response to CRT was defined 
as an absolute reduction in LV ESV ≥ 15% at FU echo-
cardiography [5]. This study was approved by the Insti-
tutional Review Board of Yonsei University, Severance 
Hospital, Seoul, Korea (IRB No: 1-2013-0061). Written 
informed consent by the patients was waived due to a 
retrospective nature of our study.
Echocardiographic methods 
LV end-diastolic volume (EDV) and ESV were measured 
using biplane disc methods from apical four-chamber 
and two-chamber views [8]. LV end-diastolic volume in-
dex (EDVI) and end-systolic volume index (ESVI) were 
LV EDV and ESV indexed for body surface area (BSA). 
LV ejection fraction (EF) was calculated using LV vol-
umes. LA volume was calculated using the biplane area 
method. LA volume index (LAVI) was LA volume in-
dexed BSA. Mitral inflow velocities were obtained using 
pulse wave Doppler in the apical four-chamber view. 
Early mitral inflow velocity (E) and late diastolic velocity 
were also measured, and the early mitral annular (e′) ve-
locity was recorded from the septal mitral annulus. The 
E/e′ ratio was then calculated. Diastolic function was as-
sessed by transmitral and tissue Doppler. According to 
mitral inflow and tissue Doppler pattern, patients were 
divided into grade 1 to 3 as follows: grade 1, relaxation 
abnormality; grade 2, pseudonormalization; and grade 
3, restrictive LV filling pattern [9]. The calculated systol-
ic pulmonary artery pressure was defined as: 4 × (maxi-
mum velocity of tricuspid regurgitant jet)2 + right atrial 
pressure. Right atrial pressure was estimated by measur-
ing the inferior vena cava diameter and its response to 
inspiration [10].
Mitral regurgitation (MR) was graded as grade 0 to 4. 
The qualitative, semiquantative, and quantitative pa-
rameters used to grade MR were standard criteria based 
on the American Society of Echocardiography recom-
mendations [11]. Changes between baseline and early FU 
(Δ) values were calculated for LV ESVI (ΔLV ESVI), LV EF 
(ΔLV EF), LAVI (ΔLAVI), E (ΔE) velocity, E/e′ (ΔE/e′), and 
MR (ΔMR) grade.
Clinical events
Patients who underwent baseline echocardiography 
were followed up across a median of 22 months (inter-
quartile range, 12 to 33) for a composite endpoint that in-
cluded cardiac death and inpatient admission for heart 
failure. The occurrence of clinical events was ascer-
tained by reviewing hospital records and by telephone 
interview, as necessary.
Statistical analysis
Variables are presented as mean ± standard deviation 
or number (%). Paired t tests were used to compare 
time-course changes for echocardiographic variables 
after CRT device implantation. Groups were compared 
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using chi-square statistics for categorical variables and 
Student’s t test for continuous variables. If distributions 
were skewed, the Mann-Whitney U or Kruskal-Wallis 
nonparametric tests were used as appropriate. The cor-
relation among changes in echocardiographic variables 
was assessed using Pearson’s correlation coefficient for 
Table 1. Baseline characteristics of study population
Variable Total population (n = 97)
LAVR at early FU
LAVR (n = 48) No LAVR (n = 49) p value
Age, yr 66 ± 12 66 ± 11 66 ± 13 0.947
Women 46 (47.4) 22 (42.5) 24 (49.0) 0.756
Body surface area, m2 1.63 ± 0.19 1.62 ± 0.17 1.63 ± 0.21 0.927
Ischemic 12 (12.4) 4 (8.3) 8 (16.8) 0.232
CRT-P 24 (24.7) 15 (31.3) 9 (18.4) 0.142
Baseline ECG findings
LBBB 69 (71.1) 34 (70.8) 35 (71.4) 0.948
QRS duration, msec 163.6 ± 21.9 166.3 ± 22.4 160.8 ± 21.2 0.216
Medication
ACEI/ARB 86 (88.7) 40 (83.3) 46 (93.3) 0.102
Beta-blocker 65 (67.0) 36 (75.0) 29 (59.2) 0.098
Spironolactone 58 (59.8) 30 (62.5) 28 (57.1) 0.590
Echocardiography
LV EDVI, mL/m2 138.2 ± 53.5 140.2 ± 49.7 136.2 ± 57.5 0.716
LV ESVI, mL/m2 106.1 ± 47.4 108.6 ± 45.7 103.7 ± 49.3 0.616
LV EF, % 24.6 ± 6.2 24.2 ± 7.1 24.9 ± 5.2 0.578
LAVI, mL/m2 51.8 ± 21.9 55.4 ± 23.3 48.3 ± 20.1 0.110
E velocity, cm/sec 77.2 ± 29.5 78.6 ± 33.0 75.9 ± 25.8 0.657
e′ velocity, cm/sec 4.1 ± 1.8 4.1 ± 1.8 4.0 ± 1.7 0.692
E/e′ 21.1 ± 10.7 21.5 ± 12.2 20.7 ± 9.1 0.712
SPAP, mmHg 38.2 ± 16.2 41.7 ± 18.7 34.4 ± 14.6 0.059
MR grade 0.682
Grade 0 27 (27.8) 14 (29.2) 13 (26.5)
Grade 1 22 (22.7) 8 (16.7) 14 (28.6)
Grade 2 21 (21.6) 12 (25.0) 9 (18.4)
Grade 3 22 (22.7) 11 (22.9) 11 (22.4)
Grade 4 5 (5.2) 3 (6.2) 2 (4.1)
Diastolic function 0.589
Grade 1 47 (48.5) 23 (47.9) 24 (49.0)
Grade 2 11 (11.3) 4 (8.3) 7 (14.3)
Grade 3 39 (40.2) 21 (43.8) 18 (36.7)
Values are presented as mean ± SD or number (%).
LAVR, left atrial volume reduction; FU, follow-up; CRT-P, cardiac resynchronization therapy-pacemaker; ECG, electrocardiog-
raphy; LBBB, left bundle branch block; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; 
LV, left ventricular; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; EF, ejection fraction; LAVI, left atrial 
volume index; E velocity, early mitral inflow velocity; e′ velocity, early mitral annular velocity; SPAP, systolic pulmonary artery 
pressure; MR, mitral regurgitation.
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variables with a normal distribution and Spearman’s 
correlation coefficient for those with a non-normal dis-
tribution. To determine the independent factors asso-
ciated with LAVR, univariate and multivariate logistic 
regression analyses were performed. A p value < 0.05 was 
considered statistically significant.
RESULTS
Echocardiography was performed in all 97 patients at 
baseline and at early FU (100.0%) and in 83 patients at 
late FU (85.6%). Late FU echocardiography was lost in 
14 patients, including seven patients with cardiovascu-
lar mortality within 1 year after CRT and seven patients 
who had not undergone late FU echocardiography after 
1 year. Early and late FU echocardiography were per-
formed at a median of 6 months (interquartile range, 4 
to 7) and 30 months (interquartile range, 21 to 38), re-
spectively. 
Baseline characteristics
Table 1 shows baseline characteristics of the study pop-
ulation. The mean age was 66 ± 12 years, and 46 patients 
(47.4%) were women. Ischemic heart failure was present 
in 12 patients (12.4%). Left bundle branch block (LBBB) 
was identified in 69 patients (71.1%), and mean QRS du-
ration was 163.6 ± 21.9 msec. CRT pacemakers were im-
planted in 24 patients (24.7%). Median LAVR at early FU 
was 7.5%. There were no significant differences in base-
line characteristics including diverse echocardiographic 
variables between LAVR and no LAVR groups. 
Echocardiographic data
Mean LV ESVI and LAVI at baseline were 106.1 ± 47.4 
and 51.8 ± 21.9 mL/m2, respectively. As shown in Fig. 1, 
LV ESVI continuously decreased from baseline to early 
FU (106.1 ± 47.4 mL/m2 vs. 87.6 ± 51.6 mL/m2, p < 0.001) 
and from early to late FU (87.6 ± 51.6 mL/m2 vs. 72.5 ± 
57.1 mL/m2, p < 0.001). In contrast, LAVI significantly de-
creased from baseline to early FU (51.8 ± 21.9 mL/m2 vs. 
45.1 ± 19.6 mL/m2, p < 0.001), but there were no signifi-
cant reductions thereafter (45.1 ± 19.6 mL/m2 vs. 44.9 ± 
23.0 mL/m2, p = 0.599).
Echocardiographic data at baseline, early FU, and late 
FU are shown in Table 2. LV EDVI, LV EF, MR grade, 
and diastolic function grade showed continuous chang-
es from baseline to early FU and from early to late FU, 
similar to the changing pattern of LV ESVI. E velocity 
and E/e′ decreased from baseline to early FU, but there 
were no reductions thereafter, similar to the changing 
pattern of LAVI. There were no significant changes in e′ 
velocity from baseline to early FU (4.1 ± 1.8 cm/sec vs. 3.9 
± 1.3 cm/sec, p = 0.216), and e′ velocity increased at late FU 
(3.9 ± 1.3 cm/sec vs. 4.3 ± 1.3 cm/sec, p = 0.025). 
Factors associated with LAVR at early FU
Fig. 2 demonstrates simple correlations of ΔLAVI to 
Figure 1. Time course changes in left ventricle and left atrium. (A) Left ventricular end-diastolic volume index (LV ESVI). (B) 
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ΔE velocity, ΔE/e′, ΔLV ESVI, and ΔLV EF. There were 
significant positive correlations between ΔLAVI and 
ΔE velocity (r = 0.616, p < 0.001) and between ΔLAVI and 
ΔE/e′ (r = 0.494, p < 0.001). However, no significant cor-
relations were found between ΔLAVI, ΔLV ESVI, and 
ΔLV EF. Table 3 shows the results of logistic regression 
analysis for factors associated with LAVR at early FU. 
In univariate analysis, ΔLV ESVI, ΔEF, ΔE velocity, and 
ΔE/e′ were associated with LAVR (all p < 0.05), whereas 
baseline echocardiographic variables did not show any 
association with LAVR. In multivariate analysis, ΔE ve-
locity was the only independent factor associated with 
LAVR, even after adjusting for ΔLV ESVI, ΔLV EF, ΔE/e′, 
and ΔMR grade (odds ratio [OR], 1.04; 95% CI, 1.02 to 
1.07; p = 0.002). 
Fig. 3 compares diastolic function before and early 
after CRT for the LAVR groups. There were no signif-
icant differences in diastolic function between the two 
groups at baseline before CRT (p = 0.589). There were 
more patients with grade 1 (87.5% vs. 53.1%) than grade 
3 (10.4% vs. 35.4%) diastolic function in the LAVR group 
(p = 0.001).
Factors associated with LV response to CRT
Among all 97 patients after CRT, 55 patients (56.7 %) 
had early LV response. The number of LV responses 
increased at FU, and 60 of 83 patients (72.3 %) had LV 
response at late FU. Fig. 4 compares the prevalence of 
LV response between LAVR groups according to FU 
period. There were no significant differences in LV re-
sponse rates at early FU between the two groups (64.6% 
vs. 49.0%, p = 0.121). However, LV response rate at late 
FU was significantly higher in the LAVR group at ear-
ly FU (83.3% vs. 61.0%, p = 0.029). ΔLV ESVI at late FU 
was higher in those with early LAVR compared to those 
without early LAVR (–26.3 ± 29.0 mL/m2 vs. –11.0 ± 24.8 
Table 2. Comparison of time-course changes in echocardiographic variables 
Variable Baseline (n = 97) Early FU (n = 97) Late FU (n = 83)
LV EDVI, mL/m2 138.2 ± 53.5 120.2 ± 81.1a 108.1 ±62.3a,b
LV ESVI, mL/m2 106.1 ± 47.4 87.6 ± 51.6a 72.5 ± 57.1a,b
LV EF, % 24.6 ± 6.2 31.1 ± 10.9a 38.1 ± 13.8a,b
LAVI, mL/m2 51.8 ± 21.9 45.1 ± 19.6a 44.9 ± 23.0a
E velocity, cm/sec 77.2 ± 29.5 64.2 ± 27.0a 64.9 ± 23.5a
e′ velocity, cm/sec 4.1 ± 1.8 3.9 ± 1.3 4.3 ± 1.3b
E/e′ 21.1 ± 10.7 18.1 ± 9.8a 16.8 ± 10.0 a
SPAP, mmHg 38.2 ± 16.2 37.1 ± 16.5 33.0 ± 11.2
MR grade
Grade 0 27 (27.8) 40 (41.2)a 39 (47.0)a,b
Grade 1 22 (22.7) 20 (20.6) 23 (27.7)
Grade 2 21 (21.6) 19 (19.6) 7 (8.4)
Grade 3 22 (22.7) 15 (15.5) 11 (13.3)
Grade 4 5 (5.2) 3 (3.1) 3 (3.6)
Diastolic function
Grade 1 47 (48.5) 68 (70.1)a 58 (69.9)a,b
Grade 2 11 (11.3) 7 (7.2) 12 (14.5)
Grade 3 39 (40.2) 22 (22.7) 13 (15.7)
Values are presented as mean ± SD or number (%).
FU, follow-up; LV, left ventricular; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; EF, ejection fraction; 
LAVI, left atrial volume index; E velocity, early mitral inflow velocity; e′ velocity, early mitral annular velocity; SPAP, systolic 
pulmonary artery pressure; MR, mitral regurgitation.
ap < 0.05 compared with baseline.
bp < 0.05 compared with early follow-up. 
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mL/m2, p = 0.006), as well as percent changes in LV ESVI 
(–24.8% ± 25.2% vs. –12.7% ± 26.4%). Table 4 demon-
strates multivariate analysis for determinants of late 
LV response. LAVR at early FU (OR, 6.94; 95% CI, 1.40 
to 34.37; p = 0.018) and LVVR at early FU (OR, 12.35; 95% 
CI, 2.65 to 57.62) were independent predictors for the late 
response, even after adjustment for gender, LBBB, QRS 
duration, and baseline LV ESVI and LAVI. 
Clinical events and LAVR
Over the course of the study period, 26 patients (26.8%) 
experienced the composite endpoint. Specifically, 13 pa-
tients (13.4%) experienced death from cardiac causes and 
13 patients (13.4%) experienced inpatient admissions for 
heart failure. Fig. 5 shows event-free survival rates for 
the composite endpoint stratified by LAVR at early FU. 
Patients with early LAVR demonstrated a trend of favor-
able event-free survival compared to those without early 
LAVR (log-rank p = 0.066).
DISCUSSION
The principal findings of the current study examining 
longitudinal changes in LV and LA volume after CRT 
were that: (1) LAVR occurred early (median 6 months) 
after CRT whereas LVVR was sustained through the 
long-term FU period (median 30 months); (2) LAVR was 
Figure 2. Simple correlation between changes in left atrial volume index (LAVI) and other echocardiographic variables. (A) 
Early mitral inflow velocity. (B) Early mitral to mitral annular velocity ratio. (C) Left ventricular end-systolic volume index (LV 
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closely associated with changes in E velocity and mitral 
inflow pattern, suggesting its relation with LV filling 
pressure and optimization of mitral inflow pattern; (3) 
early significant LAVR was closely related to long-term 
LV response to CRT.
Time course changes of LAVR and LVVR
CRT induces favorable changes in LV activation pattern, 
thus improving cardiac performance and reducing LV 
ESV [12,13]. Because CRT response is usually defined 
according to the percentage of LV ESV reduction [14], 
LVVR is an important determining factor for outcomes 
and functional improvement in patients with CRT de-
Table 3. Factors associated with higher left atrial volume reduction at early follow-up 
Variable
Univariate Multivariate
OR (95% CI) p value OR (95% CI) p value
Baseline echocardiography
LV ESVI 1.00 (0.98–1.01) 0.613 - -
LV EF 1.02 (0.96–1.09) 0.572 - -
LAVI 0.99 (0.97–1.00) 0.985 - -
E velocity 1.00 (0.98–1.01) 0.652 - -
E/e′ 0.99 (0.96–1.03) 0.708 - -
MR grade 0.93 (0.68–1.28) 0.853 - -
Early follow-up echocardiography
ΔLV ESVI 1.01 (1.00–1.02) 0.011 1.01 (0.99–1.03) 0.363
ΔLV EF 0.95 (0.90–1.00) 0.043 0.95 (0.89–1.02) 0.163
ΔE velocity 1.04 (1.02–1.06) < 0.001 1.04 (1.02–1.07) 0.002
ΔE/e′ 1.06 (1.02–1.11) 0.006 1.00 (0.94–1.05) 0.846
ΔMR grade 1.42 (0.99–2.04) 0.055 1.22 (0.79–1.89) 0.371
OR, odds ratio; CI, confidence interval; LV, left ventricular; ESVI, end-systolic volume index; EF, ejection fraction; LAVI, left 
atrial volume index; E velocity, early mi tral inflow velocity; e′ velocity, early mitral annular velocity; MR, mitral regurgitation; 
Δ values, changes between baseline and early follow-up. 
Figure 3. Comparison of changes in diastolic function before cardiac resynchronization therapy (CRT) and at early follow-up 
(FU) between left atrial volume reduction (LAVR) and no LAVR. (A) Diastolic function grade before CRT. (B) Diastolic function 
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vice implants [2]. LVVR after CRT was reported to be a 
better predictor of long-term survival than clinical re-
sponse evaluated by improvement in New York Heart 
Association class or the 6 minutes walking test [15]. 
LVVR usually accompanies LAVR [16-18], but discrep-
ant LAVR and LVVR has been reported in approximate-
ly 20% of patients at 1 year after CRT, in which patients 
with discordant LA and LVVR showed more favorable 
outcomes compared to lesser volume reduction of both 
chambers [5]. LAVR was maximized in the earlier peri-
od compared to LVVR and then stagnated, suggesting 
a discrepancy in the time-course changes of LA and LV 
volume that resulted in discrepant LAVR and LVVR at 1 
year after CRT. LAVR was also a predictor for late LV re-
sponse. Therefore, more favorable outcomes in patients 
with discordant LA and LVVR compared to lesser vol-
ume reduction of both chambers could be explained by 
this time gap in which LVVR follows LAVR. More than 
1 year long-term FU is necessary to define LV response 
to CRT, especially in patients with a favorable LAVR 
during the early FU period.
Associated factors with LAVR
We found that ΔE velocity or ΔE/e’ was more associated 
with early LAVR than ΔLV ESV or ΔLV EF. That is, 
LAVR was more closely related to hemodynamic vari-
ables during diastole, such as E velocity, E/e′, and MR 
severity rather than LV volumetric or functional param-
eters. This finding also explains the discrepant LAVR 
and LVVR values after CRT [5], which might be because 
different factors determine LAVR and LVVR. 
Interestingly, E velocity was the most important factor 
for early LAVR in our study. It was more important than 
E/e′, a well-known estimation of LV filling pressure. E 
velocity is directly influenced by LA pressure and LV 
diastolic function, whereas e′ is influenced by LV relax-
Figure 4. Comparison of left ventricular (LV) response between left atrial volume reduction (LAVR) and no LAVR. (A) Preva-









































Table 4. Multivariate analysis for predictors of left ventricular response at late follow-up 
Variable Odds ratio 95% Confidential interval p value
Female gender 1.61 0.35–7.43 0.541
LBBB 3.55 0.67–18.84 0.137
QRS duration 0.95 0.95–1.02 0.292
LV ESVI, baseline 0.99 0.97–1.01 0.150
LAVI, baseline 0.98 0.95–1.02 0.342
LAVR at early FU 6.94 1.40–34.37 0.018
LVVR at early FU 12.35 2.65–57.62 0.001
LBBB, left bundle branch block; LV, left ventricular; ESVI, end-systolic volume index; LAVI, left atrial volume index; LAVR, 
left atrial volume reduction; FU, follow-up; LVVR, left ventricular volume response.
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ation and independent of LA pressure. E/e′, correcting 
E velocity for the influence of relaxation (e′), is tradi-
tionally considered to reflect LV filling pressure [19]. A 
plausible explanation for the stronger association of E 
velocity to LAVR over E/e′ in the current study is that e′ 
is unreliable in LBBB or biventricular pacing, resulting 
in inaccurate E/e′ for assessing LV filling pressure [20]. 
E velocity adjusted by CRT optimization [21,22] could be 
the most important determinant for LAVR following 
CRT since E/e′ or e′ may be inaccurate in populations 
of electrical dyssynchrony and severe heart failure [22]. 
Larger in-depth studies are warranted to definitively 
identify any association between E velocity, diastolic 
functional recovery, and CRT optimization.
LAVR as surrogate marker for CRT response
Both LAVR and LVVR at early FU were independent 
factors for long-term CRT response. Since echocar-
diographic CRT response is usually defined using the 
criteria of 15% reduction of LVESV, it is not surpris-
ing that early LVVR was an independent predictor for 
long-term CRT response in the current study. More 
interestingly, early LAVR independently predicted fu-
ture CRT response. LAVR has been reported to predict 
clinical outcomes in patients with a CRT device implant 
[3,4,23]. In addition to LV systolic function, several fac-
tors may be involved in the pathophysiology of LAVR in 
patients with heart failure after CRT device implanta-
tion. According to Frank-Starling’s law, LA enlargement 
may occur as a compensatory mechanism to maintain 
LA stroke volume when LV filling pressure is elevated 
[24,25]. Reduction of LV filling pressure and LA pressure 
leads to decreased LA size. MR, caused by distortion of 
the mitral apparatus in the presence of dyssynchrony, 
may be reduced by CRT with a consequent decrease in 
LA pressure and volume [13]. CRT may induce LAVR 
through optimization of atrioventricular and interven-
tricular delay [26-28], as efficient ventricle preloading 
through a properly timed atrial contraction has been 
shown to improve stroke work [29]. Considering the 
above-described factors, LAVR is a useful surrogate 
marker reflecting complex variables such as LA pres-
sure, MR severity, and atrioventricular optimization af-
ter CRT device implantation. LAVR could be used as a 
surrogate marker for optimally adjusted status of CRT 
for each individual after device implantation. This ex-
plains why LAVR at early FU, a marker for early CRT op-
timization, predicted favorable LVVR during long-term 
FU. The clinical impact of early LAVR demonstrated a 
trend for favorable clinical outcomes (combined cardiac 
death and inpatient hospitalization) in the early LAVR 
group. Further studies with large numbers of patients 
are warranted.
Limitations
The current findings were based on a retrospective anal-
ysis, which prevents inference of a causal relationship 
among the variables. Nevertheless, all medical records 
and echocardiographic images were carefully reviewed 
to avoid possible biases. This was a pilot study, and fur-
ther larger studies are required to conclude this hypoth-
esis. Our study population consisted of a high preva-
lence of women and non-ischemic cardiomyopathy. 
Therefore, application of this data to other populations 
should be cautious. Data regarding functional status of 
the left atrium is lacking, and further studies using LA 
functional variables such as strain would be useful to 
better define the relationship of LA size and function to 
CRT response. Since changes in E velocity were related 
to changes in LV volume, early LA volume changes may 
Figure 5. Comparison of event free survival rate for com-
posite cardiovascular events stratified by left atrial volume 
reduction (LAVR) at early follow-up.  
n = 97
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be partially influenced by early changes in LV volume. 
However, mitral inflow pattern reflecting LV diastolic 
properties was also profoundly improved in the early 
LAVR group, suggesting improved diastolic dysfunction 
in the early phase of this group. Clinical data reflecting 
exercise performance, such as cardiopulmonary exer-
cise tests and 6-minute walking tests, are lacking in this 
study. CRT optimization and medications, including 
dosages of each drug for heart failure, were adminis-
tered according to the attending physician’s preference 
for each patient. There was no standardized protocol for 
the entire study population.
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